Posted by Reuters: Business News on February 3, 2012
NEW YORK (Reuters) – Stock index futures edged higher on Friday as investors awaited the monthly payrolls report to see whether to make more large bets in risk assets after recent equity gains.



Source >>>
Posted by Reuters: Business News on February 2, 2012
NEW YORK (Reuters) – Stocks edged higher on Thursday after weekly jobless claims fell in the latest week, but gains were limited as investors were reluctant to make big bets ahead of Friday’s payrolls report and a recent rally.



Source >>>
Posted by Reuters: Business News on January 3, 2012
LONDON (Reuters) – Better-than-expected data from China’s giant manufacturing sector boosted global stocks and the euro on Tuesday and pushed safe-haven bets like German bonds lower.



Source >>>
Posted by Reuters: Business News on December 30, 2011
NEW YORK (Reuters) – Stocks edged lower on Friday, the last trading day of 2011, as investors waited for next year to begin making large bets.



Source >>>
Posted by Reuters: Business News on
NEW YORK (Reuters) – Stocks opened little changed on Friday, the last trading day of 2011, as investors waited until next year to begin making large bets.



Source >>>
Posted by Reuters: Business News on
NEW YORK (Reuters) – Stock index futures were little changed on Friday, the last trading day of 2011, as investors waited until the next year to begin making large bets.



Source >>>
Posted by Reuters: Business News on December 27, 2011
NEW YORK (Reuters) – Stock index futures were little changed on Tuesday as investors found little reason to make big bets in what was expected to be a light-volume session following the previous week’s gains.



Source >>>
Posted by Reuters: Business News on
NEW YORK (Reuters) – Stock index futures were lower on Tuesday as investors found little reason to make big bets in what was expected to be a light-volume session following the previous week’s gains.



Source >>>
Posted by Reuters: Business News on November 21, 2011
(Reuters) – Gilead Sciences Inc struck a deal to buy biotechnology company Pharmasset Inc for about $11 billion in a huge and risky bet on the next generation of hepatitis C treatments.



Source >>>
Posted by Reuters: Business News on November 11, 2011
NEW YORK/CHICAGO (Reuters) – MF Global fired all 1,066 of its brokerage employees on Friday, triggering anger and resentment about the firm’s collapse after bad bets on European debt under former CEO Jon Corzine’s leadership.



Source >>>